HMOs fulfill a multitude of critical roles, encompassing their function as prebiotic substrates for beneficial gut microbes [13,14,15], their capacity to reduce the risk of infection by serving as soluble decoy receptors [16,17], and their ability to modulate the immune system through binding to cell surface receptors on both epithelial and immune cells [18]. The gene discussed is CD177; the disease is infection.